✦ LIBER ✦

Phase II trial of pegylated liposomal doxorubicin plus docetaxel with and without trastuzumab in metastatic breast cancer: Eastern Cooperative Oncology Group Trial E3198

✍ Scribed by Antonio C. Wolff; Molin Wang; Hailun Li; Michael R. Pins; Florence J. Pretorius; Kendrith M. Rowland; Joseph A. Sparano; Nancy E. Davidson

Publisher: Springer US
Year: 2010
Tongue: English
Weight: 311 KB
Volume: 121
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-010-0838-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of trastuzumab plus wee

A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group Trial

✍ Stacy Moulder; Hailun Li; Molin Wang; William J. Gradishar; Edith A. Perez; Jose 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 250 KB

Randomized phase III trial of trastuzuma

Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group

✍ Kenichi Inoue; Kazuhiko Nakagami; Mitsuhiro Mizutani; Yasuo Hozumi; Yasuhiro Fuj 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 368 KB

Pegylated liposomal doxorubicin and tras

Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial

✍ Elmar Stickeler; Maximilian Klar; Dirk Watermann; Annette Geibel; Martha Földi; 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 276 KB

A Phase II trial of cisplatin plus WR-27

A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma : An Eastern Cooperative Oncology Group Study (E8188)

✍ William J. Gradishar; Patricia Stephenson; Donna J. Glover; Donna S. Neuberg; Me 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

Docetaxel and irinotecan in recurrent or

Docetaxel and irinotecan in recurrent or metastatic head and neck cancer : A phase 2 trial of the Eastern Cooperative Oncology Group

✍ Athanassios Argiris; Ashley Buchanan; Bruce Brockstein; Jill Kolesar; Musie Gheb 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 2 views

Methotrexate, vinblastine, doxorubicin,

Methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic breast cancer. A phase II trial of the hoosier oncology group

✍ Bruce J. Roth; George W. Sledge Jr; Stephen D. Williams; Steven C. Meyer; Rafat 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB 👁 2 views

Forty-six eligible patients with metastatic breast cancer (MBC) were treated with a combination of methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) as first-line chemotherapy. Of 44 patients evaluable for response, 28 (64%) had an objective response, including seven (16%) who had a comp